JM 295
Alternative Names: JM-295Latest Information Update: 11 Feb 2024
At a glance
- Originator JMackem
- Class Analgesics
- Mechanism of Action Glycine plasma membrane transport protein inhibitors; Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Pain
Most Recent Events
- 19 Dec 2023 Early research in Pain in South Korea (unspecified route) (JMackem pipeline; December 2023)